Pricing Log in Create free account

NexGel, Inc. (NXGL) vs Regentis Biomaterials Ltd. (RGNT)

NexGel, Inc. and Regentis Biomaterials Ltd. are both Medical Instruments & Supplies companies. NexGel, Inc. is the larger, with a market value of $12.7M against $8.2M — 1.5× the size. Across the 9 metrics below, Regentis Biomaterials Ltd. leads on 7 and NexGel, Inc. on 2.

Valuation

Metric NXGL RGNT Medical Instruments & Supplies median
P/E n/m — 30.28
P/S 0.15 — 2.49
P/B 0.32 n/m 2.34
Price to free cash flow n/m n/m 23.49
EV/EBITDA n/m n/m 14.87
EV/Sales 0.32 n/m 2.75
Earnings yield (363.17%) — 0.00%
Free cash flow yield (189.42%) 0.00% 0.59%

Profitability

Metric NXGL RGNT Medical Instruments & Supplies median
Gross margin 35.08% — 53.60%
Operating margin (44.77%) — 1.97%
Net margin (51.26%) — 0.00%
Free cash flow margin (27.66%) 0.00% 2.36%
Return on equity (117.57%) 0.00% 0.00%
Return on assets (34.21%) 0.00% 0.00%
Return on invested capital (45.29%) 0.00% 0.13%

Growth

Metric NXGL RGNT Medical Instruments & Supplies median
Revenue growth (TTM) 3.38% — 8.97%
EPS growth (last fiscal year) 24.00% (1,504.65%) 6.51%
Revenue growth, 5-year CAGR 76.12% — 8.85%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric NXGL RGNT Medical Instruments & Supplies median
Debt to equity 0.68 0.00 0.10
Current ratio 0.43 5.62 2.47
Net debt to EBITDA 0.13 0.89 0.97

Dividend

Metric NXGL RGNT Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric NXGL RGNT Medical Instruments & Supplies median
Market cap 12.65m 8.22m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack